SAN DIEGO, CA--(Marketwired - Jun 29, 2017) - Youngevity International, Inc. (
Used for centuries in Ayurvedic and Chinese medicine, Tumeric has been known to be an anti-inflammatory agent. According to Memorial Sloan Kettering Cancer Center, there are ongoing clinical trials to substantiate Eastern Medicine use of Tumeric and laboratory and animal studies do suggest that Tumeric can reduce inflammation in animals. Anti-oxidants have become a recognized element of good nutrition, helping the body to combat free radicals by safely neutralizing them and preventing and reducing the damage they can cause to cells.
"We are proud to offer a powerful, organically sourced product that delivers the reported anti-oxidant benefits of curcumin," stated Steve Wallach, CEO and Co-Founder of Youngevity. "Pürmeric is our newest addition to the Youngevity Performance product line - which addresses exercise performance-based nutritional needs that supports athletes and weekend warriors alike with nutritional benefits tailored to their pursuit of fitness."
"Pürmeric delivers yet another example of our commitment to offering quality and science when we create a nutritional product or supplement," stated Dave Briskie, President and CFO of Youngevity. "We are not in the business of offering 'me-too' products. We are in the business of offering robust product entries that can compete strongly across the supplement spectrum."
Youngevity was founded upon the pioneering principles of Dr. Joel Wallach; always looking forward to the betterment of society. Today Youngevity seeks to continue to meet this mission with groundbreaking products, innovative services and a fulfilling business opportunity individually defined through flexibility and personal lifestyle choices. And in this Pursuit of Betterment, the Company continues to build and grow its Youngevity Be The Change Foundation. 100% of the profits from Youngevity Be the Change Coffee, and other special products highlighted on the Foundation website finance Foundation operations.
About Youngevity International, Inc.
Youngevity International, Inc. (
Safe Harbor Statement
This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. In some cases forward-looking statements can be identified by terminology such as "may," "should," "potential," "continue," "expects," "anticipates," "intends," "plans," "believes," "estimates," and similar expressions. These forward-looking statements are based on management's expectations and assumptions as of the date of this press release and are subject to a number of risks and uncertainties, many of which are difficult to predict that could cause actual results to differ materially from current expectations and assumptions from those set forth or implied by any forward-looking statements. Important factors that could cause actual results to differ materially from current expectations include, among others, our ability to continue to meet the continued listing requirements of The NASDAQ Capital Market and our ability to continue our financial performance and the other factors discussed in our Annual Report on Form 10-K for the year ended December 31, 2016 and our subsequent filings with the SEC, including subsequent periodic reports on Forms 10-Q and 8-K. The information in this release is provided only as of the date of this release, and we undertake no obligation to update any forward-looking statements contained in this release on account of new information, future events, or otherwise, except as required by law.